Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
MgShell manufactures intraocular devices for treating exudative form of age-related macular degeneration.
MSInsight bioinformatics start-up that develops diagnostic and treatment response prediction solutions for MSI cancers.
Braingaze develops mind tracking solutions that solve major challenges around cognitive disorders like ADHD and Mild Cognitive Impairment
Affirma Biotech is a pre-clinical startup which develops host-directed drugs as treatments for chronic and infection diseases.
In vitro diagnostic company that develops a rapid test for a faster sepsis diagnose through host immune system status.
Exheus is provider of direct-to-consumer gene expression report that helps to optimise people’s health in a highly personalised way.
Inrobics proposes a rehabilitation model using artificial intelligence and social robots.
Kintsugi Therapeutics is a biopharmaceutical company that develops innovative therapies.
FrontWave Imaging is a developer of supercomputing software that helps with the diagnosis of breast cancer.
Biohope is dedicated to the development of diagnostic and therapeutic solutions for organ transplantation.
MJN develops high-technology innovative devices to predict epileptic seizures
Cebiotex offers manufacturing technology and contract research in the field of drug delivery with electrospun nanofiber technology.
QMENTA is a software development company that offers AI cloud-based solutions for imaging clinical trials and studies.
Tractivus is a producer of implantable medical devices.
Rithmi is the pioneering company of Computational Predictive Care.
A precise and portable in-vitro device that brings efficiency to the hematological diseases diagnostics with a single blood drop.
A new generation of skin-regeneration products
Wearable soft robotics for neural recovery
Davalor Salud is the health sector that develops and makes commercial use of hardware and software for the exploration.
Ducentis is a pre-clinical stage company that aims to develop novel therapies for inflammation and autoimmune disease.
ZeClinics is a Start-up CRO offering an outsourcing solution for safety and efficacy screenings of novel chemical molecules using zebrafish.
Bioprognos is a spin-off of the Hospital Clínic of Barcelona that aims to improve clinical outcomes and quality of life for cancer.
Capital Cell has invested in 46 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Capital Cell's top investment sectors include Health Care, Biotechnology, Medical, Medical Device, Health Diagnostics. The firm invests across 22 different industry categories.
Among tracked funding rounds, ZeClinics received $2.0M in a Grant round. Capital Cell's total known invested capital is $102.4M.
Capital Cell's average investment size is $2.9M across its portfolio of 46 companies.
Recent Capital Cell portfolio additions include MgShell, MSInsight, Braingaze, Affirma Biotech, Loop Dx. These companies were founded in 2020 or later.